These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2174493)

  • 1. Interactions of cryptosin with mammalian cardiac dihydropyridine-specific calcium channels.
    Rao VR; Banning JW
    Life Sci; 1990; 47(18):1667-76. PubMed ID: 2174493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of cryptosin with mammalian cardiac beta-adrenoceptors.
    Rao VR; Banning JW
    Drug Chem Toxicol; 1990; 13(2-3):173-94. PubMed ID: 1980455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of propionyl-L-carnitine on L-type calcium channels in human heart sarcolemma.
    Bevilacqua M; Vago T; Norbiato G
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():31-5. PubMed ID: 1851633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The failure of endothelin to displace bound, radioactively-labelled, calcium antagonists (PN 200/110, D888 and diltiazem).
    Gu XH; Liu JJ; Dillon JS; Nayler WG
    Br J Pharmacol; 1989 Feb; 96(2):262-4. PubMed ID: 2538185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoaffinity labeling of the calcium channel antagonist receptor in the heart of the cardiomyopathic hamster.
    Kuo TH; Johnson DF; Tsang W; Wiener J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):926-33. PubMed ID: 2446613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyridine receptor binding sites in the cardiomyopathic hamster heart are unchanged from control.
    Bazan E; Sole MJ; Schwartz A; Johnson CL
    J Mol Cell Cardiol; 1991 Feb; 23(2):111-7. PubMed ID: 1648625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-dependent binding of dihydropyridine calcium channel blockers to guinea pig ventricular myocytes.
    Kamp TJ; Sanguinetti MC; Miller RJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1240-7. PubMed ID: 2849670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of the cardiac 1,4-dihydropyridine receptor/calcium channel complex.
    Rengasamy A; Ptasienski J; Hosey MM
    Biochem Biophys Res Commun; 1985 Jan; 126(1):1-7. PubMed ID: 2982362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.
    Doble A; Benavides J; Ferris O; Bertrand P; Menager J; Vaucher N; Burgevin MC; Uzan A; Gueremy C; Le Fur G
    Eur J Pharmacol; 1985 Dec; 119(3):153-67. PubMed ID: 2419140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors.
    Herbette LG; Vant Erve YM; Rhodes DG
    J Mol Cell Cardiol; 1989 Feb; 21(2):187-201. PubMed ID: 2545886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of (+)-PN 200-110 to rat pituitaries and to normal and adenomatous human pituitaries.
    Bression D; Chaumet-Riffaud P; Brandi AM; Comte A; Peillon F; Kiechel JR
    Mol Cell Endocrinol; 1987 Apr; 50(3):255-61. PubMed ID: 3032711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptational process of the cardiac Ca2+ channels to pressure overload: biochemical and physiological properties of the dihydropyridine receptors in normal and hypertrophied rat hearts.
    Mayoux E; Callens F; Swynghedauw B; Charlemagne D
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):390-6. PubMed ID: 2465438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of dihydropyridine-sensitive calcium channels by the plant alkaloid ryanodine.
    Valdivia HH; Coronado R
    FEBS Lett; 1989 Feb; 244(2):333-7. PubMed ID: 2537759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
    Miwa K; Miyagi Y; Araie E; Sasayama S
    Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid procedure for the purification of cardiac 1,4-dihydropyridine receptors from porcine heart.
    Haase H; Striessnig J; Holtzhauer M; Vetter R; Glossmann H
    Eur J Pharmacol; 1991 May; 207(1):51-9. PubMed ID: 1655494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism.
    Young HS; Skita V; Mason RP; Herbette LG
    Biophys J; 1992 May; 61(5):1244-55. PubMed ID: 1318093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global ischemia increases the density of voltage-dependent calcium channels in porcine cardiac sarcolemma.
    Blanck TJ; Yasukochi S; Quigg M; Curtis WE; Gardner TJ
    Anesth Analg; 1997 May; 84(5):972-5. PubMed ID: 9141917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Rasmussen RP; Minobe W; Bristow MR
    Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptosin induces backbone structural changes in cardiac Na+ and K+ dependent adenosinetriphosphatase.
    Venkateswara RR; Dipak D; Banning JW; Vaidyanathan CS
    Biochem Int; 1990 Oct; 22(2):287-94. PubMed ID: 1965277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.